NAAA
GILD icon

New Age Alpha Advisors’s Gilead Sciences GILD Stock Holding History

New Age Alpha Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Sell
88,072
-2,045
-2% -$269K 0.47% 38
2026
Q1 		$12.6M Sell
90,117
-8,223
-8% -$1.15M 0.59% 23
2025
Q4 		$12.1M Sell
98,340
-3,264
-3% -$397K 0.52% 33
2025
Q3 		$11.3M Sell
101,604
-6,467
-6% -$735K 0.47% 35
2025
Q2 		$12M Buy
108,071
+9,562
+10% +$1.02M 0.53% 29
2025
Q1 		$11M Sell
98,509
-18,177
-16% -$1.88M 0.49% 28
2024
Q4 		$10.8M Buy
+116,686
New +$10.5M 0.44% 42

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New Age Alpha Advisors's GILD Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, selling an estimated $269K and leaving 88,072 shares worth $11.1M. The position accounts for 0.47% of the portfolio, ranked #38.

New Age Alpha Advisors first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.6M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • New Age Alpha Advisors held 88,072 shares of Gilead Sciences worth $11.1M as of Q2 2026.
  • New Age Alpha Advisors sold 2,045 Gilead Sciences shares in Q2 2026, an estimated $269K.
  • Gilead Sciences made up 0.47% of New Age Alpha Advisors's portfolio in Q2 2026, its #38 holding.
  • New Age Alpha Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • New Age Alpha Advisors's Gilead Sciences position peaked at $12.6M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.